The epidemiology of epilepsy in Europe – a systematic review

By L. Forsgren, E. Beghi, A. Oun, M. Sillanpää. European Journal of Neurology, 2005

790 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Cost of disorders of the brain in Europe (2005, background): “All reviews resulted in articles which were published early 2005 (Berr et al., 2005; Campenhausen et al., 2005; Fehm et al., 2005; Forsgren et al., 2005; Goodwin et al., 2005; Lieb et al., 2005; Paykel et al., 2005; Pini et al., 2005; Pugliatti et al., 2005; Rössler et al., 2005; Rehm et al.,…”
The consequences of refractory epilepsy and its treatment. (2014, background): “The prevalence of epilepsy in developed countries ranges between 4 and 10 per 1,000 individuals per year [2,20,21], with much greater prevalence rates in developing and resource-poor countries [2], and some estimates at greater than 130 per 1000 individuals per year [3,24].”
The global burden and stigma of epilepsy. (2008, neutral): “The great majority of studies of the prevalence of epilepsy have reported rates between 4 and 10 per 1000 [1,8,9].”
Prevalence and incidence of epilepsy (2017, result): “This finding is consistent with previous studies of the epidemiology of epilepsy in Europe.(6) Elevated mortality could prevent the lifetime prevalence of epilepsy from increasing significantly with age (particularly in older age groups) when the incidence of epilepsy is not zero, as is the case her”